Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ABBOTT LABORATORIES
Report date April 29, 2011 · Filed May 03, 2011
Section 16 reporting ended · disclosed 2011-05-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 10,522 |
Reported balance
After 2011-04-29 transaction · row 1
1 source rowRow 1 · 2011-04-29 · Tax withholding · Disposed 3,674 · Balance 10,522 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2011 Filed May 3, 2011 21:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,674 | $52.29 | $192,113.46 |
DisclosureSEC source: 0001179110-11-007243 · edgar.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,522 Read SEC document |
| April 23, 2010 Filed Apr 27, 2010 22:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-007465 · edgar.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,196 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,413 | $0.00 Strike: $37.42 | $0.00 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · derivative · entry 8 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,413 shares Expires 2013-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,616 | $0.00 Strike: $42.73 | $0.00 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · derivative · entry 7 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,616 shares Expires 2011-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,900 | $54.44 | $103,437.90 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · nonDerivative · entry 6 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,088 Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.44 | $5,444.03 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · nonDerivative · entry 5 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,988 Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,929 | $54.44 | $540,534.76 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · nonDerivative · entry 4 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,088 Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.44 | $5,444.11 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · nonDerivative · entry 3 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,017 Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,413 | $37.42 | $239,993.06 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · nonDerivative · entry 2 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2010 Filed Mar 20, 2010 00:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,616 | $42.73 | $239,987.40 |
DisclosureSEC source: 0001179110-10-005771 · edgar.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,010 | $0.00 Strike: $35.92 | $0.00 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · derivative · entry 7 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,010 shares Expires 2010-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.28 | $10,856.32 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · nonDerivative · entry 6 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,088 Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.28 | $5,428.15 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · nonDerivative · entry 5 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,288 Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 110 | $54.28 | $5,970.93 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · nonDerivative · entry 4 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,388 Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $54.28 | $97,705.80 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · nonDerivative · entry 3 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498 Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $54.28 | $151,989.60 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · nonDerivative · entry 2 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,298 Read SEC document |
| February 19, 2010 Filed Feb 23, 2010 00:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,010 | $35.92 | $179,955.19 |
DisclosureSEC source: 0001179110-10-003403 · edgar.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2009 Filed Apr 28, 2009 22:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-026809 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,088 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 25, 2008 Filed Apr 30, 2008 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 5,985 | $0.00 Strike: $51.12 | $0.00 |
DisclosureSEC source: 0001104659-08-028092 · a4.xml · derivative · entry 2 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,985 Underlying: common shares · 5,985 shares Expires 2018-04-25 F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 25, 2008 Filed Apr 30, 2008 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-028092 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,623 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 28, 2008 Filed Mar 28, 2008 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,306 | $53.31 | $69,619.99 |
DisclosureSEC source: 0001104659-08-020852 · a4.xml · nonDerivative · entry 2 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,706 Read SEC document |
| March 27, 2008 Filed Mar 28, 2008 22:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,318 | $54.20 | $613,435.60 |
DisclosureSEC source: 0001104659-08-020852 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012 F1 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| April 27, 2007 Filed May 1, 2007 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-034477 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,266 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program). F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-030330 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,479 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program). F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018230 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,255 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| May 03, 2004 Filed May 5, 2004 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 339 | $42.32 Strike: $0.00 | $14,346.48 |
DisclosureSEC source: 0001104659-04-012728 · a4.xml · derivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653 Underlying: common shares · 339 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 5,825 | $0.00 Strike: $41.20 | $0.00 |
DisclosureSEC source: 0001104659-04-011391 · a4.xml · derivative · entry 2 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,825 Underlying: common shares · 5,825 shares Expires 2014-04-22 F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b). It contains a replacement option feature. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,577 | $41.20 | $64,972.40 |
DisclosureSEC source: 0001104659-04-011391 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,133 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.